Combined Therapy With Peginterferon Alfa-2a With NA in NA-treated HBeAg Positive Patients

NCT02474316 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

366

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: Peginterferon alfa-2a
DRUG: nucleos(t)ide analgoue

Sponsor

Ruijin Hospital